Owlstone Medical Ltd (Owlstone Medical) is a diagnostic company that develops and commercializes breathalyzers for use in clinical diagnostics and precision medicines. It offers FAIMS Technology for medical applications, Lonestar for disease biomarker detection and ATLAS for volatile organic compounds sampling from clinical sample. Owlstone Medical provides UltraFAIMS for enhanced mass spectrometry for medical research simulated human breath (SiHuB) products, CASPER that provides clean air supply for portable use in clinics and respiration collector for in vitro analysis (ReCIVA) breath sampler. The company’s products are used in applications such as lung cancer, asthma, tuberculosis, bowel (colorectal) cancer, coeliac disease and irritable bowel syndrome, inflammatory bowel disease, drug metabolites in urine, and propofol detection and monitoring. It operates offices in Cambridge and London, the UK. Owlstone Medical is headquartered in Cambridge, England, the UK.
This report is a source for data, analysis, and actionable intelligence on the company’s portfolio of pipeline products. The report provides key information about the company, its major products and brands.
The report enhances decision making capabilities and help to create effective counter strategies to gain competitive advantage.
Scope:
The report reviews detailed company profile with information on business description, key company facts, major products and services, key competitors, key employees, locations and subsidiaries and recent developments
The report analyzes all pipeline products in development for the company Owlstone Medical Ltd
The report provides pipeline analysis on all pipeline products of the company (by equipment type, by indication, by development stage, and by trial status)
The report covers detailed information on each pipeline product with information on pipeline territory, stage of development, device class, regulatory path, indication(s), application(s) and estimated launch date
The report provides detailed description of products in development, technical specification and functions
The report also covers ongoing clinical trials (wherever applicable) with information on trial name, trial objective, sponsor, trial design , trial status and phase, estimated start and end date.
Reasons to Buy:
Develop business strategies by understanding the trends and developments driving the medical devices pipeline and technology landscape
Design and develop your product development, marketing and sales strategies by understanding the competitor portfolio
To formulate effective Research & Development strategies
Develop market-entry and market expansion strategies
Exploit in-licensing and out-licensing opportunities by identifying products, most likely to ensure a robust return
Plan mergers and acquisitions effectively by identifying key players of the most promising pipeline
Identify emerging players with potentially strong product portfolio and create effective counter-strategies to gain competitive advantage
Develop competition strategies by identifying the status and likely launch of the competitors’ pipeline products through review of the clinical trials, stage and of development, etc
Identify, understand and capitalize the next high-value products that your competitor would add in its portfolio
Note:Some sections may be missing if data is unavailable for the company
Owlstone Medical Ltd Company Overview
Owlstone Medical Ltd Company Snapshot
Owlstone Medical Ltd Pipeline Products and Ongoing Clinical Trials Overview
Owlstone Medical Ltd – Pipeline Analysis Overview
Owlstone Medical Ltd - Key Facts
Owlstone Medical Ltd - Major Products and Services
Owlstone Medical Ltd Pipeline Products by Development Stage
Owlstone Medical Ltd Ongoing Clinical Trials by Trial Status
Owlstone Medical Ltd Pipeline Products Overview
Breath Biopsy Digestive Health Test - Food Intolerance
Breath Biopsy Digestive Health Test - Food Intolerance Product Overview
Breath Biopsy Digestive Health Test - Small Intestine Bacterial Overgrowth
Breath Biopsy Digestive Health Test - Small Intestine Bacterial Overgrowth Product Overview
Breath Biopsy Test - Pulmonary Hypertension
Breath Biopsy Test - Pulmonary Hypertension Product Overview
Diagnostic Test - Aspergillus Lung Infection
Diagnostic Test - Aspergillus Lung Infection Product Overview
Diagnostic Test - Aspergillus Lung Infection Clinical Trial
Diagnostic Test - Lung Transplant Rejection
Diagnostic Test - Lung Transplant Rejection Product Overview
ReCIVA Breath Sampler - Cancer
ReCIVA Breath Sampler - Cancer Product Overview
ReCIVA Breath Sampler - Colorectal Cancer
ReCIVA Breath Sampler - Colorectal Cancer Product Overview
ReCIVA Breath Sampler - Colorectal Cancer Clinical Trial
ReCIVA Breath Sampler - Lung Cancer
ReCIVA Breath Sampler - Lung Cancer Product Overview
STRATA Breath Test
STRATA Breath Test Product Overview
Owlstone Medical Ltd - Key Competitors
Owlstone Medical Ltd - Key Employees
Owlstone Medical Ltd - Locations And Subsidiaries
Head Office
Other Locations & Subsidiaries
Recent Developments
Owlstone Medical Ltd, Recent Developments
Dec 09, 2023: Owlstone Medical Publishes Data on the use of an EVOC Probe for the Early Detection of Liver Cirrhosis
Oct 10, 2023: Owlstone Medical Recruits First Patient in Phase 2 Clinical Trial for the Early Detection of Lung Cancer through Breath Biopsy
Jun 22, 2023: Owlstone Medical Presents Data Demonstrating Progress in Development of Breath Biopsy Tests for Liver Cirrhosis and NASH
Jun 14, 2023: Owlstone Medical Presents Data Demonstrating Progress in Development of Breath Biopsy Test for the Early Detection of Lung Cancer
May 17, 2023: Owlstone Medical wins contract from U.S. Department of Defense to develop handheld breath biopsy device for early infectious disease detection
Mar 03, 2023: Four diagnostic products in the pipeline at SQI
Feb 06, 2023: Owlstone Medical publishes data on the use of exhaled volatile organic compounds as biomarkers for liver disease detection
Dec 07, 2022: Owlstone Medical launches breath biopsy VOC Atlas
Jan 24, 2022: SQI Diagnostics signs MOU with UK-based Owlstone Medical
Jul 20, 2021: Owlstone Medical publishes data on the use of face mask filters to capture viral particles for SARS-CoV-2 detection
Appendix
Methodology
About GlobalData
Contact Us
Disclaimer
List of Tables
Table 1: Owlstone Medical Ltd Pipeline Products and Ongoing Clinical Trials Overview
Table 2: Owlstone Medical Ltd Pipeline Products by Equipment Type
Table 3: Owlstone Medical Ltd Pipeline Products by Indication
Table 4: Owlstone Medical Ltd, Key Facts
Table 5: Owlstone Medical Ltd, Major Products and Services
Table 6: Owlstone Medical Ltd Number of Pipeline Products by Development Stage
Table 7: Owlstone Medical Ltd Pipeline Products Summary by Development Stage
Table 8: Owlstone Medical Ltd Ongoing Clinical Trials by Trial Status
Table 9: Owlstone Medical Ltd Ongoing Clinical Trials Summary
Table 10: Breath Biopsy Digestive Health Test - Food Intolerance - Product Status
Table 11: Breath Biopsy Digestive Health Test - Food Intolerance - Product Description
Table 12: Breath Biopsy Digestive Health Test - Small Intestine Bacterial Overgrowth - Product Status
Table 13: Breath Biopsy Digestive Health Test - Small Intestine Bacterial Overgrowth - Product Description
Table 14: Breath Biopsy Test - Pulmonary Hypertension - Product Status
Table 18: Diagnostic Test - Aspergillus Lung Infection - A Preliminary Clinical Study of Non-invasive Breath Diagnostic Technology for the Early and Accurate Detection of Organ Rejection
Table 19: Diagnostic Test - Lung Transplant Rejection - Product Status